Full Text
Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial- Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36

Abstract

Authors

S Cano S Cleanthous P Marquis J Hobart S Naoshy D Mikol J Petrillo D Steiner C Watson

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×